Vivos Therapeutics, Inc. (VVOS)
Treats sleep apnea and jaw problems using custom dental devices and therapy.
$0.42+0.03%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-92.0%
The outlook
VVOS is trading near its 52-week lows with a bearish overall score. The stock sits well below both its 50- and 200-day averages, signaling a downtrend, though analyst price targets average substantially higher than the current price.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +409% vs current price
Analyst price target
~12-month · 3 analysts$2.12average target+408.7% vs now
Now $0.42
Low $0.75High $3.10
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.8M
52-wk high
$5.69
52-wk low
$0.36
50-day avg
$0.54
200-day avg
$1.48
Trailing P/E
—